Novartis's $642 million "kickback door" is tied, and how can the medical permanators on the compliance route take on the burden?

Guide: Medical compliance, how to reduce the weight to continue to move forward!the U.SDepartment of Justice's official website on July 1, Novartis paid $642 million to settle allegations of improper payments to patients and doctorsNovartis Pharmaceuticals, a pharmaceutical company based in East Hanover, New Jersey, has agreed to pay a separate settlement of $642m to settle allegations of violations of the False Claims Act (FCA)The first settlement relates to the company's alleged illegal use of three foundations as a conduit to pay for medical insurance patients enrolled in Novartis' drugs Gilenya and AfinitorThe second settlement settled claims arising from the company's alleged kickbacks to doctorsJune 27, the Central Commission for Discipline Inspection, the state supervision committee official website published the "observation, how to deal with the pharmaceutical field bribery and bribery of many parties together to investigate" article, to Lishui City Center Hospital in Zhejiang Province, the former director of anesthesiology Lei Lipei received a total of 3.32 million yuan in rebates from new morning medicine and other pharmaceutical enterprises, as an example, put forward the treatment of bribery in the field of medicine, to join forces, bribery togetherJune 2020, the Medical Administration and Hospital Authority on the issuance of 2020 to correct the pharmaceutical purchase and sale of the field and medical services in the main points of work, pointed out that serious investigation and punishment of the collection of pharmaceutical supplies enterprises rebatesTo carry out special management against the collection of kickbacks by practitioners of medical institutions, and to investigate and punish the acts of medical institutions and medical personnel using their practice to obtain improper benefits and collect kickbacksfocus on the inspection of medical institutions employees to accept drugs, medical equipment, medical hygiene materials and other pharmaceutical products production, business enterprises or distribution personnel in various names, forms of rebatesThe medical personnel who are verified shall be dealt with seriously in accordance with the law, and the illegal clues that the pharmaceutical product operators involved in the case give kickbacks shall be handed over to the market regulatory departments, and the enterprises involved in the administrative punishment shall be made public through the national enterprise credit information publicity systemExplore the establishment of enterprise credit evaluation and disciplinary mechanismcan be seen that the country pays more and more attention to the medical and pharmaceutical industry compliance development, the medical industry more stringent supervision, and in recent years for the reform of medical and pharmaceutical, the medical perpeople has been a matchthe pharmaceutical industry is already exhausted, still have to carry the burden of moving forward
the recent major pharmaceutical companies have been updating compliance policies, requiring more compliant behavior to promote products, these changes will foreshadow the 2020 pharmaceutical market more stringent, which is closely related to national policiesit is understood that further on the pharmaceutical companies to increase flight inspection efforts, the implementation of 1 hour in advance flight inspection notice, informed the conference organizers 1 hour later will be a third party to participate in the inspection, which made everyone surprised, with the previous 1 day notice, has been shortened to 1 houralso require stouer to ask doctors to lecture the entire video, the meeting time must not be less than 20 minutes, and the doctor lecture fee should not exceed 1000 yuan, from time and cost to double control, no doubt to strangle those "air will." is not only foreign enterprises, domestic enterprises with the 4-7 policy landing, centralized procurement gradually become the normal mechanism, the Chinese market and foreign market pattern convergence, domestic enterprises may start foreign pharmaceutical enterprises for a hundred years to promote the old road According to industry news, there have been domestic pharmaceutical companies began to carry out a compliance revolution, will order meals, purchase brand tips platform to the Internet, centralized procurement management, this will undoubtedly represent the behavior of locked, basically representthe the value of the "human flesh." pharmaceutical compliance, how to reduce the burden of continuing the deepening of national policies, pharmaceutical companies more stringent compliance, no doubt on the two categories of people have a profound impact: the first category: pharmaceutical sales staff pharmaceutical sales staff need to invest more time and energy to reflect their own value the daily behavior of the past pharmaceutical sales staff is to provide doctors with academic value-related derivative customer conditions, with the enterprise compliance requirements, the proportion of fees moved up, the representative cost reduction, the future pharmaceutical sales staff can only fight, need to invest more time and energy to maintain customer conditions the academic research of innovative pharmaceutical products and new products, the representative needs to turn to innovative pharmaceutical companies with the landing of 4 plus 7, most of the over-patented drugs will be 4 plus 7, in fact, in foreign patented products equivalent to generic drugs, academic value decreased, will no longer need academic promotion Therefore, only innovative drugs to doctors have academic value, pharmaceutical sales staff to innovative pharmaceutical companies is a trend Online outflow of "still passive 4 plus 7, not as active As the active Gilead, efficient operation of the 8 rounds of interviews, two weeks out of results" let us lament such a global innovation pharmaceutical company iconic enterprises, seeking good the explosion of domestic research and development and related enterprises, leading to the flow of high-quality pharmaceutical sales staff to research and development-oriented enterprises China's research and development companies are springing up, with data showing that 250,000 high-end biopharmaceutical researchers have returned from abroad over the years, which will boost the level of research and development of Chinese pharmaceutical companies and increase demand for pharmaceutical sales high-quality pharmaceutical sales staff has a medical or pharmaceutical background, if you have a graduate degree, the future is unlimited the second category: drug prescription leaders doctors' psychological expectations of pharmaceutical sales staff are lowered With the progress of hospital reforms, the survival of doctors is also improving, all parties are calling for improving the living environment of doctors, from social identity to life security in terms of improvement, from the Health Insurance Bureau and health care committee documents have pointed out that the health insurance balance fund will be used for doctors performance bonus especially in the outbreak phase, the number of hospital patients fell sharply, resulting in unsustainable hospital operations, especially the pilot reform of public hospitals, doctors' bonuses, the same period pharmaceutical companies reduced academic activity, the double blow affecting the overall income of doctors tough compliance policies, doctors are because of their compliance awareness doctors also agree to some extent that compliance is a protection for themselves, so the expectation of providing value to pharmaceutical sales staff is also declining Nowadays, exposure events, increased awareness of physician compliance, but also deep understanding of corporate compliance policies, often recommend edified on how to do more compliance, which is also a sign of the progress of China's pharmaceutical industry for compliance policy we have to look rationally, objectively, if with emotional look at compliance will be bound to be eliminated by the wave of the times, this era is, you can keep up, you can not keep up with also have to go